Abnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated Cardiomyopathy

Journal of Diabetes Research
Domenico TricòAndrea Natali

Abstract

Dilated cardiomyopathy (DCM) is characterized by a metabolic shift from fat to carbohydrates and failure to increase myocardial glucose uptake in response to workload increments. We verified whether this pattern is influenced by an abnormal glucose tolerance (AGT). In 10 patients with DCM, 5 with normal glucose tolerance (DCM-NGT) and 5 with AGT (DCM-AGT), and 5 non-DCM subjects with AGT (N-AGT), we measured coronary blood flow and arteriovenous differences of oxygen and metabolites during Rest, Pacing (at 130 b/min), and Recovery. Myocardial lactate exchange and oleate oxidation were also measured. At Rest, DCM patients showed a reduced nonesterified fatty acids (NEFA) myocardial uptake, while glucose utilization increased only in DCM-AGT. In response to Pacing, glucose uptake promptly rose in N-AGT (from 72 ± 21 to 234 ± 73 nmol/min/g, p < 0.05), did not change in DCM-AGT, and slowly increased in DCM-NGT. DCM-AGT sustained the extra workload by increasing NEFA oxidation (from 1.3 ± 0.2 to 2.9 ± 0.1 μmol/min/gO2 equivalents, p < 0.05), while DCM-NGT showed a delayed increase in glucose uptake. Substrate oxidation rates paralleled the metabolites data. The presence of AGT in patients with DCM exacerbates both the shift from fat...Continue Reading

Associated Clinical Trials

References

Sep 1, 1991·The American Journal of Physiology·D BurkhoffG Gerstenblith
Mar 1, 1988·Metabolism: Clinical and Experimental·E Ferrannini
Feb 1, 1987·The Journal of Clinical Investigation·J A WisneskiM Mayr
Jul 1, 1974·The American Journal of Cardiology·W B KannelW P Castelli
Feb 1, 1993·The American Journal of Physiology·E FerranniniP G Camici
Nov 15, 2000·The American Journal of Cardiology·J P BaggerT T Nielsen
Dec 12, 2001·American Journal of Physiology. Endocrinology and Metabolism·Fabio A RecchiaWilliam C Stanley
Jul 11, 2002·Journal of the American College of Cardiology·Víctor G Dávila-RománRobert J Gropler
Sep 6, 2003·Journal of the American College of Cardiology·Michael DomanskiUNKNOWN BEST Investigators
Sep 30, 2003·Diabetes Care·Alain G BertoniFrederick L Brancati
Feb 28, 2004·Diabetes Care·Alain G BertoniDavid C Goff
Apr 15, 2004·Journal of Molecular and Cellular Cardiology·Biao LeiFabio A Recchia
Jul 28, 2004·Diabetes Care·Gregory A NicholsJonathan B Brown
May 21, 2005·Biochimica Et Biophysica Acta·Andrew N Carley, David L Severson
Jul 1, 2005·Physiological Reviews·William C StanleyGary D Lopaschuk
Sep 27, 2005·European Heart Journal·Osvaldo Pereztol-ValdésJordi Soler-Soler
Jun 6, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Ding An, Brian Rodrigues
Jul 25, 2007·Circulation·Houman AshrafianLionel H Opie
Oct 9, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Danilo NegliaFabio A Recchia
Feb 6, 2008·Cardiovascular Drugs and Therapy·Terje S Larsen, Ellen Aasum
Feb 28, 2009·Journal of the American College of Cardiology·Matlooba A AlZadjaliChim C Lang
Jan 21, 2010·Physiological Reviews·Gary D LopaschukWilliam C Stanley
May 11, 2010·Current Opinion in Clinical Nutrition and Metabolic Care·Aslan T TurerMihai V Podgoreanu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.